Novavax is up nearly tenfold this year, but it's not too late to profit from the outcome of its COVID-19 vaccine trial. Read More
Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.
Analyst Articles
This little known index correctly predicted the past two stock market corrections. Here's how to profit from its next change in direction. Read More
This online retailer has soared more than 500% over the past six weeks and appears to be headed for a big fall. Read More
There's an intriguing pattern to the stock market's behavior that presents a profit opportunity for options traders. Read More
Small-cap stocks are cheap and many large-caps can acquire them without incurring debt or depleting cash. Read More
If these three stocks reverse direction and start heading down, the U.S. stock market probably won’t be far behind. Read More
We correctly called the market's top and bottom. Now we face several months of sideways action. Here's how to profit. Read More
The markets may be telling us that the strong U.S. dollar is about to weaken. If so, this fund will score big. Read More
This fund should benefit from the unwinding of the flight to safety that is bound to happen once the coronavirus has passed. Read More
This ETF is in a sector that's getting hit hard now but could rebound strongly once the virus is contained. Read More